<p><strong>在本次免费网络研讨会中，了解如何提高细胞系开发中的单克隆性保证。与会者将获得通过纳米液滴和全孔明场成像来最小化假阳性（幽灵孔）风险的实用方法的见解。主讲人将分享利用荧光全孔成像验证 99.99% 单克隆性概率工作流程的关键策略。与会者将理解人工智能和数据集中化如何将图像分析的全职员工需求减少超过 50%。</strong></p>
<p>, /PRNewswire/ -- 确保稳定的细胞系源自单一祖细胞是蛋白质、细胞和基因疗法开发的基本组成部分。然而，单克隆性保证往往是细胞系开发中的一个限制性步骤，导致项目延迟和风险增加。</p>
<p>继续阅读</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null"/></p>
<p>http://www.novabiomedical.com/</p>
<p>在演讲中，Nova Biomedical 的 Solentim 产品组合全球产品经理 Adam Causer 将提供一个端到端工作流程的概述，该流程不仅实现 99.99% 的单克隆性概率，还数字化和自动化生成 IND 提交单克隆性证据的过程。</p>
<p>与会者将获得可操作的见解，以最小化幽灵孔风险，使用温和的自动化单细胞沉积，并概述如何在结合高通量全孔成像时实现能够提供超过 99.99% 单克隆性概率的工作流程——在使用人工智能驱动的数据管理和分析的情况下，不牺牲通量或效率。</p>
<p>请于 2026 年 2 月 24 日（星期二）参加网络研讨会，届时将进行两次直播，分别在中欧时间上午 9 点（中国时间下午 4 点）和北美东部时间上午 8 点（中欧时间下午 2 点）。</p>
<p>有关更多信息或注册此活动，请访问《提高细胞系开发中的单克隆性保证：在第 0 天看到更多》。</p>
<p><strong>关于 XTALKS</strong></p>
<p>Xtalks — 生命科学社区™ 赋能制药、生物技术、医疗技术、医疗保健和研究领域的专业人士，提供可信的知识和协作见解，推动行业向前发展。由 Honeycomb Worldwide Inc.提供支持，Xtalks 提供新闻、特写文章、网络研讨会、播客、视频、专家访谈、精心策划的工作机会等，旨在支持在快速发展的行业中做出明智的决策。</p>
<p>每年，成千上万的专业人士依赖 Xtalks 获取及时的信息、同行观点和行业思想领导力。加入我们的生命科学社区，保持信息灵通、互联互通，并为未来做好准备。</p>
<p>要了解更多关于 Xtalks 的信息，请访问 www.xtalks.com</p>
<p>有关与 Xtalks 合作举办网络研讨会的信息，请访问 https://xtalks.com/partner-with-us/</p>
<p>联系方式：</p>
<p>Vera Kovacevic</p>
<p>电话：+1 (416) 977-6555 x371</p>
<p>电子邮件：[email protected]</p>
<p>来源：Xtalks</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjA0Jk5ld3NJdGVtSWQ9Tlk3NTU0MSZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMDQwODMwUFJfTkVXU19VU1BSX19fX19OWTc1NTQx?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjA0Jk5ld3NJdGVtSWQ9Tlk3NTU0MSZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMDQwODMwUFJfTkVXU19VU1BSX19fX19OWTc1NTQx"/></p>

<p>Xtalks 将于 2026 年 2 月 24 日举办一场免费的网络研讨会，重点讨论在细胞系开发中增强单克隆性保障。会议将涵盖减少假阳性和利用先进成像技术及人工智能实现 99.99% 克隆概率的策略。来自 Nova Biomedical 的 Adam Causer 将展示一个自动化生成 IND 提交证据的端到端工作流程。与会者将学习如何减少图像分析中的全职员工需求，并提高细胞系开发的效率</p>

<p><strong>In this free webinar, learn how to improve monoclonality assurance in cell line development. Attendees will gain insight into practical ways to minimize false positive (ghost well) risk through nanodroplet and whole well brightfield imaging. The featured speaker will share key strategies for validating a workflow with 99.99% Probability of Clonality utilizing fluorescence whole well imaging. Attendees will understand how artificial intelligence and data centralization can reduce FTE demands of image analysis by over 50%.</strong></p>
<div class="lb-trans"><p><strong>在本次免费网络研讨会中，了解如何提高细胞系开发中的单克隆性保证。与会者将获得通过纳米液滴和全孔明场成像来最小化假阳性（幽灵孔）风险的实用方法的见解。主讲人将分享利用荧光全孔成像验证 99.99% 单克隆性概率工作流程的关键策略。与会者将理解人工智能和数据集中化如何将图像分析的全职员工需求减少超过 50%。</strong></p>
</div><p>, /PRNewswire/ -- Assuring that a stable cell line originates from a single progenitor cell is a fundamental component of the development of protein, cellular and gene therapies. However, monoclonality assurance is often a rate-limiting step in cell line development, leading to project delays and increased risk.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- 确保稳定的细胞系源自单一祖细胞是蛋白质、细胞和基因疗法开发的基本组成部分。然而，单克隆性保证往往是细胞系开发中的一个限制性步骤，导致项目延迟和风险增加。</p>
</div><p>Continue Reading</p>
<div class="lb-trans"><p>继续阅读</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null" alt="" original-src="https://www.prnewswire.com/news-releases/null"/></p>
<p>http://www.novabiomedical.com/</p>
<div class="lb-trans"><p>http://www.novabiomedical.com/</p>
</div><p>During the presentation, Adam Causer, Global Product Manager, Solentim Portfolio, Nova Biomedical, will provide an overview of an end-to-end workflow that not only achieves 99.99% probability of clonality but also digitalizes and automates the process of generating evidence of clonality for IND submissions.</p>
<div class="lb-trans"><p>在演讲中，Nova Biomedical 的 Solentim 产品组合全球产品经理 Adam Causer 将提供一个端到端工作流程的概述，该流程不仅实现 99.99% 的单克隆性概率，还数字化和自动化生成 IND 提交单克隆性证据的过程。</p>
</div><p>Attendees will gain actionable insights into minimizing ghost well risk using gentle, automated single‑cell deposition, and an overview of how to achieve workflows capable of delivering greater than 99.99% Probability of Clonality when combined with high‑throughput whole‑well imaging — without sacrificing throughput or efficiency through the use of AI‑powered data management and analytics.</p>
<div class="lb-trans"><p>与会者将获得可操作的见解，以最小化幽灵孔风险，使用温和的自动化单细胞沉积，并概述如何在结合高通量全孔成像时实现能够提供超过 99.99% 单克隆性概率的工作流程——在使用人工智能驱动的数据管理和分析的情况下，不牺牲通量或效率。</p>
</div><p>Join the webinar on Tuesday, February 24, 2026 with 2 live broadcasts, at 9am CET/EU-Central (4pm CST/China) and at 8am EST/N. America (2pm CET/EU-Central).</p>
<div class="lb-trans"><p>请于 2026 年 2 月 24 日（星期二）参加网络研讨会，届时将进行两次直播，分别在中欧时间上午 9 点（中国时间下午 4 点）和北美东部时间上午 8 点（中欧时间下午 2 点）。</p>
</div><p>For more information, or to register for this event, visit Enhancing Monoclonality Assurance in Cell Line Development: Seeing More at Day-0.</p>
<div class="lb-trans"><p>有关更多信息或注册此活动，请访问《提高细胞系开发中的单克隆性保证：在第 0 天看到更多》。</p>
</div><p><strong>ABOUT XTALKS</strong></p>
<div class="lb-trans"><p><strong>关于 XTALKS</strong></p>
</div><p>Xtalks — The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.</p>
<div class="lb-trans"><p>Xtalks — 生命科学社区™ 赋能制药、生物技术、医疗技术、医疗保健和研究领域的专业人士，提供可信的知识和协作见解，推动行业向前发展。由 Honeycomb Worldwide Inc.提供支持，Xtalks 提供新闻、特写文章、网络研讨会、播客、视频、专家访谈、精心策划的工作机会等，旨在支持在快速发展的行业中做出明智的决策。</p>
</div><p>Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.</p>
<div class="lb-trans"><p>每年，成千上万的专业人士依赖 Xtalks 获取及时的信息、同行观点和行业思想领导力。加入我们的生命科学社区，保持信息灵通、互联互通，并为未来做好准备。</p>
</div><p>To learn more about Xtalks, visit www.xtalks.com</p>
<div class="lb-trans"><p>要了解更多关于 Xtalks 的信息，请访问 www.xtalks.com</p>
</div><p>For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/</p>
<div class="lb-trans"><p>有关与 Xtalks 合作举办网络研讨会的信息，请访问 https://xtalks.com/partner-with-us/</p>
</div><p>Contact:</p>
<div class="lb-trans"><p>联系方式：</p>
</div><p>Vera Kovacevic</p>
<div class="lb-trans"><p>Vera Kovacevic</p>
</div><p>Tel: +1 (416) 977-6555 x371</p>
<div class="lb-trans"><p>电话：+1 (416) 977-6555 x371</p>
</div><p>Email: [email protected]</p>
<div class="lb-trans"><p>电子邮件：[email protected]</p>
</div><p>SOURCE Xtalks</p>
<div class="lb-trans"><p>来源：Xtalks</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjA0Jk5ld3NJdGVtSWQ9Tlk3NTU0MSZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMDQwODMwUFJfTkVXU19VU1BSX19fX19OWTc1NTQx" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY75541&amp;Transmission_Id=202602040830PR_NEWS_USPR_____NY75541&amp;DateId=20260204"/></p>

08:30 ET 提高细胞系开发中的单克隆性保证：在第 0 天看到更多，Xtalks 即将举办的网络研讨会